Blackstone President Donates $125 Million to Tel Aviv University
As Israel faces a doctor shortage, Jonathan Gray, the president of the investment firm Blackstone, and his wife, Mindy, are donating $125 million to Tel Aviv University's health science and medical school.
The donation, through the Grays' foundation, is the largest ever to Tel Aviv University, and is expected to allow the medical school enrollment to increase by a quarter. The funds will support, among other things, a new 600-bed dormitory, scholarships and new teaching facilities.
Israel's limited capacity for medical training has contributed to a persistent shortage of doctors. As of 2020, the number of doctors per capita was about 10 percent below the average of countries in the Organization for Economic Corporation and Development.
'When Israeli students go to study medicine abroad, some of them stay — and for us, it's a loss' Professor Ariel Porat, the university's president, said. 'This is the brain drain that people talk about in many other fields, but it's especially acute with doctors.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
This common prescription drug could reduce deaths by sepsis, study finds
Critically ill patients with sepsis who are given statins may be more likely to survive, new research suggests. Researchers set out to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4 per cent of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39 per cent reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4 per cent of statin patients died while in the intensive care unit compared with 13.6 per cent of those who did not receive statins. And during their overall hospital stay, some 11.5 per cent of sepsis patients who were given statins died, compared with 19.1 per cent of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39 per cent lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
Yahoo
16 hours ago
- Yahoo
Statins can reduce sepsis deaths, study suggests
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Sepsis can be life-threatening, but knowing the signs can save lives. Symptoms differ in adults, children, & infants under 5. Learn more: — The UK Sepsis Trust (@UKSepsisTrust) January 7, 2025 Some 14.3% of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4% of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39% reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4% of statin patients died while in the intensive care unit compared with 13.6% of those who did not receive statins. And during their overall hospital stay, some 11.5% of sepsis patients who were given statins died, compared with 19.1% of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39% lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
Yahoo
16 hours ago
- Yahoo
UN warns of surge in acute malnutrition among Gaza's young children
More than 2,700 children below the age of five in Gaza have been diagnosed with acute malnutrition, marking a steep increase in the number of children suffering from the serious medical condition since screening in February, the United Nations reports. Of almost 47,000 under-fives screened for malnutrition in the second half of May, 5.8 percent (or 2,733 children) were found to be suffering from acute malnutrition, 'almost triple the proportion of children diagnosed with malnutrition' three months earlier, the UN said on Thursday. The number of children with severe acute malnutrition requiring admission to hospital also increased by around double in May compared with earlier months, according to the report by the UN Office for the Coordination of Humanitarian Affairs (OCHA). According to data from the Nutrition Cluster cited by OCHA, more than 16,500 children below the age of five have been detected and treated for severe acute malnutrition in Gaza since January, including 141 children with complications requiring hospitalisation. Despite the increase in children suffering serious malnutrition and requiring hospitalisation, 'there are currently only four stabilisation centres for the treatment of [severe acute malnutrition] with medical complications in the Gaza Strip,' the OCHA report states. 'Stabilisation centres in North Gaza and Rafah have been forced to suspend operations, leaving children in these areas without access to lifesaving treatment,' it UN's latest warning on the health of young children in Gaza comes as the Palestinian territory's entire population deals with starvation, and the World Health Organization (WHO) warned that the enclave's 'health system is collapsing'. Issuing an appeal for the 'urgent protection' of two of Gaza's last remaining hospitals, the WHO said the 'Nasser Medical Complex, the most important referral hospital left in Gaza, and Al-Amal Hospital are at risk of becoming non-functional'. 'The relentless and systematic decimation of hospitals in Gaza has been going on for too long. It must end immediately,' the WHO said in a statement. 'WHO calls for urgent protection of Nasser Medical Complex and Al-Amal Hospital to ensure they remain accessible, functional and safe from attacks and hostilities,' it said. 'Patients seeking refuge and care to save their lives must not risk losing them trying to reach hospitals.' UN experts, medical officials in Gaza, as well as medical charities, have long accused Israeli forces of deliberately targeting health workers and medical facilities in Gaza in what has been described as a deliberate attempt to make conditions of life unliveable for the Palestinian population in the Strip.
